CD44 and cervical cancer: In vitro analysis of NPs formulation in the HeLa cervical cancer cell line and showed better cytotoxicity as compared to normal HCK1T cells in a time and dose dependant manner as compared to conventionally used pure Cis (p < .05), and thus proves a proficient CD44 mediated nanoparticle uptake in the cancer cells.